North Coast Ventures

North Coast Ventures was founded in 2006 as the North Coast Angel Fund, rebranding in recent years to reflect an expanded thesis beyond traditional angel investing. Based in Cleveland, Ohio, the firm has deployed over $90 million across 67 ventures, making it one of the most established early-stage investors in the Midwest.

The firm has undergone a meaningful thesis evolution: it now identifies its focus as Applied AI — companies building B2B software that leverages artificial intelligence to solve real operational problems, rather than AI for its own sake. This shift reflects the broader maturation of AI tooling and the opportunity to apply AI across healthcare credentialing, geospatial analytics, workforce management, and financial services.

North Coast Ventures sits at an interesting intersection of Midwest pragmatism and venture ambition. Their 400+ member network — composed of investors, entrepreneurs, and business leaders — provides portfolio companies with strategic introductions that often matter more than the capital itself. For founders outside coastal ecosystems, this network can be a genuine differentiator.

Ten exits across their portfolio, including OnShift's exit that won the NVCA Exit of the Year award, demonstrate that North Coast has a track record of identifying companies with real acquirer interest before the broader market recognizes their potential.

The firm's current deployment includes Acceleration Fund III, a ~$50 million vehicle, alongside the $130 million NCV II fund — a substantially larger vehicle that reflects growing LP confidence in the firm's ability to identify and support Midwest AI companies at scale.

North Coast Ventures has pivoted its thesis toward Applied AI — companies deploying artificial intelligence in targeted B2B contexts rather than broad AI infrastructure plays. This is a deliberate distinction: NCV looks for companies where AI solves a specific workflow problem, not companies built around the model itself.

The fund invests at the seed stage through Series A, with initial checks typically ranging from $200,000 to $300,000 from their core seed vehicles. For companies that reach Series A milestones with strong traction, NCV II — their $130 million second fund — can write meaningfully larger tickets.

Sector concentration centers on healthcare technology, financial services technology, and logistics/supply chain software. The common thread is large, fragmented industries where AI can drive meaningful efficiency gains and where Midwest operational expertise provides a genuine advantage in evaluating and supporting portfolio companies.

Geographic focus remains explicitly Midwest: Ohio, Michigan, Pennsylvania, and the broader region. NCV's Cleveland roots give them deal flow and relationship depth in these markets that coastal investors simply cannot replicate. Founders building AI-native B2B software in secondary markets often find NCV to be one of the few local investors with a meaningful check book.

NCV evaluates companies on three primary dimensions: founding team domain expertise (they prefer founders who have lived the problem they are solving), early traction signals that validate product-market fit, and a clear path to raising a meaningful Series A from top-tier investors. The firm takes board seats regularly and aims to be a lead investor at the seed stage.

The 400+ member investor community is a key differentiator. For seed-stage companies, access to experienced operators who can open customer doors and provide operational guidance often matters more than the capital. NCV has institutionalised this through their network, making it a systematic resource rather than ad hoc alumni access.

North Coast Ventures has maintained consistent deal flow through 2024 and into 2025, with recent investments including Primum Health (September 2025), a healthcare-focused company that fits the Applied AI thesis. The firm has also continued to support existing portfolio companies through follow-on rounds where milestones justify additional capital.

The launch of NCV II — a $130 million fund — marked a step change in NCV's ability to support portfolio companies through growth stages. This larger vehicle allows the firm to lead Series A rounds rather than relying on outside lead investors to set terms and evaluate companies for follow-on investment.

Notable recent funding rounds in the portfolio include companies across healthcare compliance, staffing optimization, and geospatial analytics — all sectors where AI-native workflows are displacing legacy software. The firm's active monitoring of these verticals has produced deal flow that aligns cleanly with their thesis.

NCV's 2025 activity also reflects increased attention to fintech, where embedded finance infrastructure companies like Alviere ($70M raised) have shown that Midwest founders can build large financial services businesses without a coastal address.

Due diligence timelines at NCV typically run two to four weeks from initial meeting to term sheet. Seed deals with clear traction and clean cap tables can move faster, and the firm has a reputation for being responsive when conviction is clear.

NCV's portfolio of 62 companies includes a number of names that have raised significant subsequent rounds, validating the firm's early conviction. Remesh — a real-time audience engagement platform — has raised $37.25 million, reflecting strong market traction in a space where AI-driven audience intelligence has become a competitive necessity for enterprise sales and marketing teams.

Axuall, a healthcare credentialing platform, has raised $33.4 million. The company automates the complex verification and compliance workflows that historically consumed enormous staff time at health systems and payers — a precisely the kind of operational AI application that fits NCV's thesis.

Satelytics applies geospatial analytics to environmental monitoring, using AI to process satellite and aerial imagery for industrial clients. The company's technology addresses compliance and operational intelligence problems in sectors ranging from energy to agriculture — a genuinely differentiated data business.

7signal provides WiFi performance management, deploying AI to optimize wireless network performance in enterprise environments. The company's focus on network intelligence reflects a broader trend toward AI-driven infrastructure monitoring.

Alviere ($70M raised) operates in embedded finance, building the infrastructure that allows B2B software platforms to offer financial services directly within their workflows. The company targets the long tail of SMBs who need banking, payments, and lending capabilities without managing a financial institution relationship.

Employstream, a staffing onboarding platform, and 1LogTech, a logistics technology company, round out the portfolio's B2B SaaS concentration — companies applying software and AI to workflow problems in sectors with strong Midwest operational roots.

OnShift, one of NCV's successful exits and the NVCA Exit of the Year winner, was acquired in a transaction that validated the firm's early thesis around senior care workforce management software. The exit provided meaningful returns to NCV's investor base and established credibility in the healthcare technology vertical.

AmpliFund, acquired by Euna Solutions in March 2025, was a grant management software company that demonstrated NCV's willingness to back companies in government-adjacent verticals where software automation creates genuine efficiency improvements.

NCV's investment criteria centre on three questions: Does the founding team have deep, lived experience with the problem they are solving? Has the company demonstrated early traction that validates product-market fit? And is there a credible path to a Series A led by a top-tier investor?

Domain expertise is non-negotiable. NCV has seen enough B2B SaaS pitches to quickly distinguish between founders who understand their market at a granular level and those who have surface-level familiarity. The firm's 400+ member network includes operators who have built and scaled companies in healthcare, fintech, logistics, and other verticals — they can quickly validate whether a founder's claimed expertise is real.

Traction matters, but the specific metrics vary by vertical. In healthcare SaaS, NCV looks at contract value and renewal rates. In fintech, monthly transaction volumes and take rate evolution are key. The common thread is evidence that customers are deriving value and willing to pay for it — not just signing up.

Competitive positioning is evaluated carefully. NCV prefers companies that have identified a specific wedge of a larger market and built a defensible position there, rather than companies positioning broadly against legacy incumbents. The AI layer should create genuine differentiation, not just be a marketing label applied to conventional software.

NCV evaluates the cap table as part of its diligence. Clean cap tables with reasonable dilution at the seed stage signal founder maturity, and NCV prefers to lead rounds where they have clarity on the cap table and existing investor dynamics.

Founder coachability is a qualitative factor NCV pays attention to. The firm's value-add is most meaningful when founders are willing to leverage the 400+ network and accept operational guidance. Founders who view investors purely as check-writers tend not to get the most from NCV's resources.

Warm introductions from the NCV network are the highest-probability path to a meeting. The firm tracks which portfolio CEOs and investors have referred deal flow, and a credible referral from someone with a relationship with NCV will get immediate attention from the investment team.

The NCV website (https://northcoast.vc) accepts submissions, though founders should note that cold inbound volume is high. The best cold submissions are concise, clearly articulate the problem and solution, and signal why the company fits NCV's thesis — not a generic deck pitched to every VC in the Midwest.

Regional investor relationships matter in NCV's deal sourcing. Midwest angel groups, regional bank-affiliated investors, and university-linked funds all feed deal flow into NCV. Founders who have built relationships with these ecosystem participants often find NCV to be a natural next conversation.

NCV's team is based in Cleveland and maintains relationships across Ohio State University, Case Western Reserve University, and other regional institutions that produce startup talent. Founders with Midwest academic connections can leverage those networks for warm intros.

When preparing for an NCV meeting, founders should be ready to discuss the specific problem they are solving, early traction metrics relevant to their vertical, and a clear articulation of how the AI application creates defensible differentiation. NCV will probe founders on their understanding of SaaS unit economics and customer acquisition costs.

Following up after a meeting is expected. NCV typically takes two to four weeks to reach a decision, and founders who send concise updates on milestones (new customer signings, product launches, funding from other investors) stay top of mind. Being pushy is counterproductive — being informative is not.

At the seed stage, NCV does not expect mature financials — the firm is accustomed to evaluating early-stage companies with limited historical data. What they do expect is a clear understanding of the metrics that matter in your vertical and a credible story about how early traction translates to a scalable business.

Founders should have a clean financial narrative: monthly recurring revenue metrics growth or equivalent traction metrics, churn and retention data, and a realistic burn rate and runway calculation. NCV will probe whether founders understand their customer acquisition cost and early lifetime value — even if those numbers are still nascent.

For Applied AI companies, NCV pays particular attention to the cost structure of delivering the AI solution. Founders who have thought carefully about gross margins at scale — and who can explain where AI creates SaaS unit economics advantages versus traditional software — will stand out.

Financial projections should show a realistic path to Series A milestones, not hockey-stick growth assumptions. NCV has seen thousands of seed pitches and can quickly identify founders who have not stress-tested their assumptions.

Working with a fractional CFO to prepare financial models for seed-stage fundraising is increasingly common among NCV-backed companies. A CFO can help structure the financial narrative, build credible models for early-stage metrics, and ensure that the cap table and financial controls are clean enough to survive Series A diligence from top-tier investors.

Whether you are preparing to pitch North Coast Ventures or other Midwest-focused seed funds, having professional-grade financials and data room readiness can meaningfully differentiate you from the competition. Our team has helped seed-stage companies across the region prepare for fundraising conversations with investors like NCV, Rev1 Ventures, and M25.

Exploring other venture capital firms in the Midwest and beyond? Our comprehensive collection of VC firm reviews covers investors across all stages and sectors who are actively deploying capital in early-stage technology companies.

Each review provides investment criteria, portfolio details, and practical guidance for securing funding. Whether you are raising a pre-seed round or preparing for Series A, these guides offer firm-specific intelligence rather than generic templated advice.

Midwest founders have increasingly strong options for local capital, and the region's investor ecosystem has matured significantly over the past decade. Researching investors who have genuine domain expertise in your vertical is the highest-value activity you can do before starting your fundraising process.